These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 9495453

  • 1. Inhibitory effect of alkylating modulators on the function of P-glycoprotein.
    Yang JM, Sullivan GF, Makhey DB, LaVoie EJ, Hait WN.
    Oncol Res; 1997; 9(9):477-84. PubMed ID: 9495453
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Ford JM, Bruggemann EP, Pastan I, Gottesman MM, Hait WN.
    Cancer Res; 1990 Mar 15; 50(6):1748-56. PubMed ID: 1968358
    [Abstract] [Full Text] [Related]

  • 4. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Liu Z, Lheureux F, Pouliot JF, Heckel A, Bamberger U, Georges E.
    Mol Pharmacol; 1996 Sep 15; 50(3):482-92. PubMed ID: 8794885
    [Abstract] [Full Text] [Related]

  • 5. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL, Onda K, Tanaka S, Toma T, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2002 May 15; 49(5):391-7. PubMed ID: 11976833
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of multidrug resistance by a new staurosporine derivative, NA-382, in vitro and in vivo.
    Miyamoto K, Inoko K, Wakusawa S, Kajita S, Hasegawa T, Takagi K, Koyama M.
    Cancer Res; 1993 Apr 01; 53(7):1555-9. PubMed ID: 8095855
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells.
    Lavie Y, Harel-Orbital T, Gaffield W, Liscovitch M.
    Anticancer Res; 2001 Apr 01; 21(2A):1189-94. PubMed ID: 11396162
    [Abstract] [Full Text] [Related]

  • 13. Detailed characterization of cysteine-less P-glycoprotein reveals subtle pharmacological differences in function from wild-type protein.
    Taylor AM, Storm J, Soceneantu L, Linton KJ, Gabriel M, Martin C, Woodhouse J, Blott E, Higgins CF, Callaghan R.
    Br J Pharmacol; 2001 Dec 01; 134(8):1609-18. PubMed ID: 11739236
    [Abstract] [Full Text] [Related]

  • 14. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL, Hirano T, Tanaka S, Onda K, Oka K.
    J Pharm Pharmacol; 2003 Nov 01; 55(11):1531-7. PubMed ID: 14713364
    [Abstract] [Full Text] [Related]

  • 15. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies.
    Politi PM, Arnold ST, Felsted RL, Sinha BK.
    Mol Pharmacol; 1990 Jun 01; 37(6):790-6. PubMed ID: 1972771
    [Abstract] [Full Text] [Related]

  • 16. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD.
    Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444
    [Abstract] [Full Text] [Related]

  • 17. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 01; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Reversal of multiple drug resistance by tolyporphin, a novel cyanobacterial natural product.
    Smith CD, Prinsep MR, Caplan FR, Moore RE, Patterson GM.
    Oncol Res; 1994 Aug 01; 6(4-5):211-8. PubMed ID: 7841544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.